Pulmonary Tc-99m tetrofosmin imaging: Clinical experience with detecting malignant lesions and monitoring response to therapy

Clinical Nuclear Medicine

Volumn 23, Issue 11, 1998, Pages 753-757

  Basoglu, Tarik ^a   Bernay, Irem ^a   Coskun, Candan ^a   Canbaz, Fevziye ^a   Talu, Aynur ^a   Erkan, Levent ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Imaging; Lung Cancer; Monitoring Therapy; Tc 99m Tetrofosmin

Indexed keywords

CISPLATIN; ETOPOSIDE; TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; MALE; MALIGNANT NEOPLASTIC DISEASE; RADIOISOTOPE DISTRIBUTION; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COBALT RADIOISOTOPES; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PROSPECTIVE STUDIES; RADIOISOTOPE TELETHERAPY; RADIOPHARMACEUTICALS;

EID: 0031760118     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199811000-00007     Document Type: Article

References (27)

1. Soricelli A, Cuoculo A, Tedeschi E, et al: Evaluation of brain tumors with technetium-99m-tetrofosmin and thallium-201: A preliminary report (abstract). Eur J Nucl Med 21(suppl):s6, 1994.
2. Basoglu T, Sahin M, Coskun C, et al: Technetium-99m-tetrofosmin uptake in malignant lung tumours. Eur J Nucl Med 22:687, 1995.
3. Atasever T, Gokcora N, Vural G, et al: Evaluation of malignant and benign lung lesions with 99Tcm-tetrofosmin. Nucl Med Commun 17:577, 1996.
4. Takekawa H, Tokaoka K, Tsukamoto E, et al: Visualization of lung cancer with 99Tcm-tetrofosmin imaging: A comparison with 201T1. Nucl Med Commun 18:341, 1997.
5. Nemec J, Nyvltova O, Preiningerova M, et al: Positive thyroid cancer scintigraphy using 99Tcm-tetrofosmin (Myoview): A preliminary report. Nucl Med Commun 16:694, 1995.
6. Gallowitsch HJ, Kresnik E, Mikosch P, et al: Tc-99m-tetrofosmin scintigraphy: An alternative scintigraphic method for following up differentiated thyroid carcinoma: Preliminary results. Nuklearmedizin 35:230, 1996.
7. Mansi L, Rambaldi PF, Procaccini E, et al: Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases Eur J Nucl Med 23:932, 1996.
8. Vieira MR, Weinholtz JH: Technetium-99m tetrofosmin scintigraphy in the diagnosis of breast cancer. Eur J Surg Oncol 22:331, 1996.
9. Aigner RM, Fueger GF, Zinke W, et al: 99Tcm-tetrofosmin scintigraphy in Hodgkin's disease. Nucl Med Commun 18:252, 1997.
10. Soderlund V, Jonsson C, Bauer HC, et al: Comparison of technetium-99m-MIBI and technetium-99m-tetrofosmin uptake by musculoskeletal sarcomas. J Nucl Med 38:682, 1997.
11. Kostakoglu L, Uysal U, Ozyar E, et al: A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma. Eur J Nucl Med 24:621, 1997.
12. Kao CH, ChangLai SP, Shen YY, et al: Technetium-99m-tetrofosmin SPECT imaging of lung masses: A negative study. J Nucl Med 38:1015, 1997.
13. Courtenary-Luck N, Epenetos AA, Halnan KE, et al: Antibody-guided irradiation of malignant lesions: Three cases illustrating a new method of treatment. Lancet i:1441, 1984.
14. Tonami Shuke, Yokoyoma K, Seki H, et al: Thallium-201 single-photon emission tomography in the evaluation of suspected lung cancer. J Nucl Med 30:997, 1989.
15. Duman Y, Burak Z, Erdem S, et al: The value and limitations of Tl-201 scintigraphy in the evaluation of lung lesions and post-therapy follow-up of primary lung carcinoma, Nucl Med Commun 14:446, 1993.
16. Tonami N, Yokoyama K, Shuke N, et al: Evaluation of suspected malignant pulmonary lesions with 201Tl single-photon emission computed tomography. Nucl Med Commun 14:602, 1993.
17. Kao CH, Wang SJ, Lin WY, et al: Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with Tc99m-methoxy isobutyl isonitrile. Eur J Nucl Med 20:249, 1993.
18. Hassan IM, Sahweil A, Constantinides C, et al: Uptake and kinetics of Tc99m-hexakis 3-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 14:333, 1989.
19. Lebouthillier G, Taifeller R, Lambert R, et al: Detection of primary lung cancer with 99mTc-MIBI (abstract). J Nucl Med 34(suppl):140, 1993
20. Stein R, Goldenberg DM: Prospect for the manegement of non-small-cell carcinoma of the lung with monoclonal antibodies. Chest 99:1466, 1991.
21. Abdel-Dayem HM, Scott A, Macapinlac H, et al: Tracer imaging in lung cancer. Eur J Nucl Med 21:57, 1994.
22. Arbab AS, Koizumi K, Toyama K, et al: Ion transport systems in the uptake of 99Tcm-tetrofosmin, 99Tcm-MIBI and 201Tl in a tumour cell line. Nucl Med Commun 18:235, 1997.
23. Arbab AS, Koizumi K, Toyama K, et al: Uptake of technetium- 99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 37:1551, 1996
24. De Jong M, Bernard BF, Breeman WA, et al: Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines. Eur J Nucl Med 23:1361, 1996.
25. Ballinger JR, Bannerman J, Boxen I, et al: Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: In vitro studies in multidrug-resistant breast tumor cells. J Nucl Med 37:1578, 1996.
26. Piwnica-Worms D, Chiu ML, Buding M, et al: Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 53:977, 1993.
27. Arbab AS, Koizumi K, Arai T, et al: Application of Tc-99m-tetrofosmin as a tumor imaging agent: Comparison with Tl-201. Ann Nucl Med 10:271, 1996.